Global Retirement Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.5K Sell
5,674
-2,819
-33% -$11.8K ﹤0.01% 3265
2026
Q2
$35.8K Buy
+8,493
New +$32.7K ﹤0.01% 2730
2025
Q4
$9.14K Buy
+2,713
New +$7.04K ﹤0.01% 3195
2024
Q4
$4K Buy
902
+664
+279% +$2.69K ﹤0.01% 2786
2024
Q3
$981 Buy
+238
New +$1.28K ﹤0.01% 3148
2024
Q2
– Sell
-16
Closed -$139 – 3593
2024
Q1
$139 Buy
+16
New +$194 ﹤0.01% 3284
2018
Q2
– Sell
-191
Closed -$2K – 1543
2018
Q1
$2K Hold
191
– – ﹤0.01% 1342
2017
Q4
$2K Buy
+191
New +$2.5K ﹤0.01% 1308

Other funds holding IRWD

Global Retirement Partners's IRWD Position: Q3 2026 in Review

Global Retirement Partners reduced its Ironwood Pharmaceuticals (IRWD) stake by 33% in Q3 2026, selling an estimated $11.8K and leaving 5,674 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

Global Retirement Partners first reported a position in IRWD in Q4 2017 and has held it in 8 quarters since. The position peaked at $35.8K in Q2 2026. 229 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Global Retirement Partners held 5,674 shares of Ironwood Pharmaceuticals worth $22.5K as of Q3 2026.
  • Global Retirement Partners sold 2,819 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $11.8K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q3 2026, its #3265 holding.
  • Global Retirement Partners first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
  • Global Retirement Partners's Ironwood Pharmaceuticals position peaked at $35.8K in Q2 2026.
  • 229 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.